Use of Celecoxib in Patients With Intraductal Papillary Mucinous Neoplasms (IPMNs)

Clinical trial NCT00198081 · TERMINATED

Trial details

NCT number: NCT00198081
Sponsor: Indiana University
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreas Neoplasms

Start date: 2005-09-01
Primary completion: 2012-04-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.